{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:03:49Z","timestamp":1791813829545,"version":"4.3.4"},"reference-count":50,"publisher":"BMJ","issue":"13","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:p>Atrial fibrillation (AF) is frequent in patients with rheumatic mitral stenosis (MS). Pressure overload leads to marked structural and electrical remodelling of left atrium. The frequency of persistent AF increases with age and paroxysmal, asymptomatic, AF seems even more frequent. The occurrence of AF worsens the haemodynamic tolerance of MS and markedly increases the risk of thromboembolic events. AF has a negative impact on the natural history of MS and on its outcome after commissurotomy. The respective indications of rhythm and rate control should be adapted to patient characteristics, particularly the consequences of MS, and take into account the high risk of recurrence of AF. Oral anticoagulant therapy is mandatory when AF complicates MS, regardless of its severity and CHA2DS2-VASc score. Non-vitamin K antagonists oral anticoagulants are not recommended in moderate-to-severe MS due to the lack of data. Percutaneous mitral commissurotomy does not appear to prevent the occurrence of AF in MS but should be considered as the first-line therapy when AF is associated with severe symptomatic MS, followed by the discussion of cardioversion or ablation. AF ablation should be considered in patients with mitral disease requiring intervention, but the ideal timing and techniques are difficult to determine due to the lack of appropriate specific randomised trials in patients with MS.<\/jats:p>","DOI":"10.1136\/heartjnl-2017-311425","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T17:15:16Z","timestamp":1518801316000},"page":"1062-1068","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":57,"title":["Management of atrial fibrillation in patients with rheumatic mitral stenosis"],"prefix":"10.1136","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9127-348X","authenticated-orcid":false,"given":"Bernard","family":"Iung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Leenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Extramiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"2020050721403055000_104.13.1062.1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308091"},{"key":"2020050721403055000_104.13.1062.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(98)70354-0"},{"key":"2020050721403055000_104.13.1062.3","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10109"},{"key":"2020050721403055000_104.13.1062.4","doi-asserted-by":"publisher","DOI":"10.1177\/0218492309349258"},{"key":"2020050721403055000_104.13.1062.5","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.118470"},{"key":"2020050721403055000_104.13.1062.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00357-X"},{"key":"2020050721403055000_104.13.1062.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.04.022"},{"key":"2020050721403055000_104.13.1062.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.02.026"},{"key":"2020050721403055000_104.13.1062.9","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.12.1580"},{"key":"2020050721403055000_104.13.1062.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01726-0"},{"key":"2020050721403055000_104.13.1062.11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.CIR.85.2.448","article-title":"Multicenter experience with balloon mitral commissurotomy. NHLBI Balloon Valvuloplasty Registry Report on immediate and 30-day follow-up results. The National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry Participants","volume":"85","author":"Anon","year":"1992","journal-title":"Circulation"},{"key":"2020050721403055000_104.13.1062.12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/hrt.80.4.359","article-title":"Predictors of event-free survival after percutaneous mitral commissurotomy","volume":"80","author":"Meneveau","year":"1998","journal-title":"Heart"},{"key":"2020050721403055000_104.13.1062.13","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000012143.27196.F4"},{"key":"2020050721403055000_104.13.1062.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.10.040"},{"key":"2020050721403055000_104.13.1062.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02452-9"},{"key":"2020050721403055000_104.13.1062.16","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.12.1430"},{"key":"2020050721403055000_104.13.1062.17","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO)","volume":"2016","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2020050721403055000_104.13.1062.18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0022-5223(03)00223-X","article-title":"Origin of atrial fibrillation from the pulmonary veins in a mitral patient","volume":"126","author":"Melo","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2020050721403055000_104.13.1062.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.06.016"},{"key":"2020050721403055000_104.13.1062.20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn329"},{"key":"2020050721403055000_104.13.1062.21","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000018441.64861.DE"},{"key":"2020050721403055000_104.13.1062.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.10.046"},{"key":"2020050721403055000_104.13.1062.23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/oxfordjournals.eurheartj.a062244","article-title":"Holter monitoring in patients with mitral stenosis and sinus rhythm","volume":"8","author":"Ramsdale","year":"1987","journal-title":"Eur Heart J"},{"key":"2020050721403055000_104.13.1062.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/12.suppl_B.55"},{"key":"2020050721403055000_104.13.1062.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00310-1"},{"key":"2020050721403055000_104.13.1062.26","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22068"},{"key":"2020050721403055000_104.13.1062.27","doi-asserted-by":"publisher","DOI":"10.1053\/eupc.2002.0286"},{"key":"2020050721403055000_104.13.1062.28","first-page":"802","article-title":"Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone","volume":"11","author":"Kapoor","year":"2002","journal-title":"J Heart Valve Dis"},{"key":"2020050721403055000_104.13.1062.29","first-page":"568","article-title":"Atrial fibrillation: how effectively can sinus rhythm be restored and maintained after balloon mitral valvotomy?","volume":"52","author":"Kavthale","year":"2000","journal-title":"Indian Heart J"},{"key":"2020050721403055000_104.13.1062.30","first-page":"1","article-title":"Sinus Rhythm in Rheumatic Mitral Stenosis after Balloon Mitral Valvotomy: Is it Feasible?","volume":"11","author":"Jayaram","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"2020050721403055000_104.13.1062.31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.amjcard.2003.07.045","article-title":"Conversion of rheumatic atrial fibrillation by amiodarone after percutaneous balloon mitral commissurotomy","volume":"92","author":"Liu","year":"2003","journal-title":"Am J Cardiol"},{"key":"2020050721403055000_104.13.1062.32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1253\/circj.71.1115","article-title":"Prognostic predictors of sinus rhythm control by amiodarone and electrical cardioversion in patients undergoing percutaneous transluminal mitral valvuloplasty for rheumatic atrial fibrillation","volume":"71","author":"Guo","year":"2007","journal-title":"Circ J"},{"key":"2020050721403055000_104.13.1062.33","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1253\/circj.69.1074","article-title":"Percutaneous transvenous mitral commissurotomy and radiofrequency catheter ablation in patients with mitral stenosis","volume":"69","author":"Miyaji","year":"2005","journal-title":"Circ J"},{"key":"2020050721403055000_104.13.1062.34","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.080325"},{"key":"2020050721403055000_104.13.1062.35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ihj.2016.02.013","article-title":"A randomized placebo-controlled trial with amiodarone for persistent atrial fibrillation in rheumatic mitral stenosis after successful balloon mitral valvuloplasty","volume":"68","author":"Vilvanathan","year":"2016","journal-title":"Indian Heart J"},{"key":"2020050721403055000_104.13.1062.36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ihj.2015.11.013","article-title":"Evaluation of early direct current cardioversion for maintenance of sinus rhythm in rheumatic atrial fibrillation following successful balloon mitral valvotomy","volume":"68","author":"Sharma","year":"2016","journal-title":"Indian Heart J"},{"key":"2020050721403055000_104.13.1062.37","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90307-9"},{"key":"2020050721403055000_104.13.1062.38","first-page":"e521","article-title":"AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"2014","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"key":"2020050721403055000_104.13.1062.39","first-page":"2939","article-title":"ESC\/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"2017","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"2020050721403055000_104.13.1062.40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"AHA\/ACC Focused Update of the 2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"2017","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2020050721403055000_104.13.1062.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.12.041"},{"key":"2020050721403055000_104.13.1062.42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1540-8167.2009.01625.x","article-title":"Hybrid therapy of radiofrequency catheter ablation and percutaneous transvenous mitral commissurotomy in patients with atrial fibrillation and mitral stenosis","volume":"21","author":"Machino","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2020050721403055000_104.13.1062.43","doi-asserted-by":"publisher","DOI":"10.5603\/KP.2013.0193"},{"key":"2020050721403055000_104.13.1062.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2003.11.018"},{"key":"2020050721403055000_104.13.1062.45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm378"},{"key":"2020050721403055000_104.13.1062.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500528"},{"key":"2020050721403055000_104.13.1062.47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.athoracsur.2016.10.076","article-title":"The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation","volume":"103","author":"Badhwar","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2020050721403055000_104.13.1062.48","doi-asserted-by":"crossref","unstructured":"Bagge L , Probst J , Jensen SM , et al . Quality of life is not improved after mitral valve surgery combined with epicardial left atrial cryoablation as compared with mitral valve surgery alone: a substudy of the double blind randomized SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). Europace 2017.doi:10.1093\/europace\/eux253","DOI":"10.1093\/europace\/eux253"},{"key":"2020050721403055000_104.13.1062.49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5603\/CJ.2013.0135","article-title":"Predictors of short- and mid-term recurrence of atrial fibrillation after surgical radiofrequency ablation: a six-month transtelephonic electrocardiogram monitoring study","volume":"20","author":"Go\u015bciniak","year":"2013","journal-title":"Cardiol J"},{"key":"2020050721403055000_104.13.1062.50","first-page":"441","article-title":"Effect of Left Atrial Reduction on Restoration and Maintenance of Sinus Rhythm in Patients Undergoing Mitral Valve Replacement: A Pilot Study","volume":"64","author":"Yalcinkaya","year":"2016","journal-title":"Thorac Cardiovasc Surg"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-311425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:16:22Z","timestamp":1601057782000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-311425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":50,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2018,6,12]]},"published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1136\/heartjnl-2017-311425"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-311425","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,16]]}}}